Lazard Asset Management LLC reduced its stake in Plexus Corp. (NASDAQ:PLXS – Free Report) by 20.6% during the 1st quarter, HoldingsChannel reports. The firm owned 40,040 shares of the technology company’s stock after selling 10,403 shares during the quarter. Lazard Asset Management LLC’s holdings in Plexus were worth $8,110,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of PLXS. AQR Capital Management LLC grew its position in Plexus by 103.1% in the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock valued at $1,074,000 after acquiring an additional 4,255 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Plexus by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after acquiring an additional 705 shares during the period. United Services Automobile Association bought a new position in shares of Plexus during the first quarter valued at $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock valued at $10,197,000 after purchasing an additional 9,078 shares in the last quarter. Finally, Cetera Investment Advisers acquired a new stake in shares of Plexus in the 2nd quarter valued at $309,000. Institutional investors own 94.45% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on PLXS. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Stifel Nicolaus boosted their price target on shares of Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Zacks Research raised shares of Plexus from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Finally, Needham & Company LLC raised their price objective on shares of Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Plexus has an average rating of “Moderate Buy” and a consensus target price of $246.67.
Plexus Price Performance
Shares of PLXS stock opened at $241.99 on Friday. The stock’s fifty day moving average is $273.64 and its 200-day moving average is $233.69. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The stock has a market capitalization of $6.48 billion, a PE ratio of 35.69 and a beta of 0.88. Plexus Corp. has a 52 week low of $124.49 and a 52 week high of $307.06.
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a return on equity of 12.57% and a net margin of 4.03%.The firm’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.64 earnings per share. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities research analysts expect that Plexus Corp. will post 5.98 EPS for the current fiscal year.
More Plexus News
Here are the key news stories impacting Plexus this week:
- Positive Sentiment: Fiscal Q3 revenue rose approximately 28% year over year to $1.30 billion, exceeding the roughly $1.23 billion consensus estimate. Growth was supported by strength in the Industrial sector, program ramps and broad-based demand. Plexus’ Q3 Earnings Surpass Estimates, Revenues Increase Y/Y
- Positive Sentiment: Non-GAAP earnings were $2.32 per share, beating estimates by approximately $0.18-$0.19 and rising from $1.90 a year earlier. Gross profit increased 27.2% to $131.4 million, while operating profit grew 14.3% to $61.3 million. Plexus Non-GAAP EPS and Revenue Results
- Positive Sentiment: Management issued fiscal Q4 EPS guidance of $2.47-$2.63, well above the approximately $2.09 analyst consensus. Revenue guidance of $1.3-$1.4 billion was broadly in line with expectations but signals continued high sales levels. Plexus Earnings Report and Guidance
- Neutral Sentiment: Cash and equivalents increased 32.2% year over year to $314.1 million, although total liabilities also rose to $2.1 billion. Operating cash flow of $25.9 million was close to capital spending of $26.7 million. Plexus Q3 2026 Financial Overview
- Negative Sentiment: Third-party data showed net income attributable to common shareholders declined 4.7% year over year to $43.0 million, despite higher revenue. In addition, insider trading activity over the past six months consisted entirely of sales, including significant selling by senior executives, which may weigh on investor sentiment. Plexus Insider Trading and Earnings Data
Insiders Place Their Bets
In other Plexus news, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $264.75, for a total value of $865,732.50. Following the completion of the transaction, the executive vice president directly owned 16,266 shares of the company’s stock, valued at approximately $4,306,423.50. The trade was a 16.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $271.23, for a total transaction of $813,690.00. Following the transaction, the insider owned 10,457 shares in the company, valued at $2,836,252.11. The trade was a 22.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 20,481 shares of company stock valued at $5,519,183. Insiders own 1.78% of the company’s stock.
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Read More
- Five stocks we like better than Plexus
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
